|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
CA2265460A1
(en)
|
1996-09-11 |
1998-03-19 |
The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services |
Aav4 vector and uses thereof
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
JP2002511259A
(ja)
|
1998-04-09 |
2002-04-16 |
ジェンセット |
５’ｅｓｔおよびコードされるヒトタンパク質
|
|
AU762220B2
(en)
|
1998-05-28 |
2003-06-19 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
AAV5 vector and uses thereof
|
|
US6984517B1
(en)
|
1998-05-28 |
2006-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector and uses thereof
|
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
EP1127150B1
(en)
|
1998-11-05 |
2007-05-16 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
US20020077470A1
(en)
|
1999-04-26 |
2002-06-20 |
Walker Michael G. |
Cardiac muscle-associated genes
|
|
WO2002002765A2
(en)
*
|
2000-07-05 |
2002-01-10 |
Transgene S.A. |
Chimeric promoters for controlling expression in smooth muscle cells
|
|
WO2002053703A2
(en)
|
2001-01-05 |
2002-07-11 |
Children's Hospital, Inc. |
Aav2 vectors and methods
|
|
SG10202108118RA
(en)
|
2001-11-13 |
2021-08-30 |
Univ Pennsylvania |
A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
|
|
ES2975413T3
(es)
|
2001-12-17 |
2024-07-05 |
Univ Pennsylvania |
Secuencias de serotipo 8 de virus adenoasociado (AAV), vectores que las contienen y usos de las mismas
|
|
ES2526341T3
(es)
|
2001-12-17 |
2015-01-09 |
The Trustees Of The University Of Pennsylvania |
Secuencias de serotipo 9 de virus adeno-asociado (AAV), vectores que las contienen, y usos de las mismas
|
|
PL2357189T3
(pl)
|
2003-06-19 |
2017-08-31 |
Genzyme Corporation |
Wiriony AAV o zmniejszonej immunoreaktywności i ich zastosowanie
|
|
US9233131B2
(en)
|
2003-06-30 |
2016-01-12 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
HUE054805T2
(hu)
|
2003-09-30 |
2021-09-28 |
Univ Pennsylvania |
Adeno-asszociált vírus (AAV) kládok, szekvenciák, az azokat tartalmazó vektorok és alkalmazásaik
|
|
AU2005316476A1
(en)
|
2004-12-15 |
2006-06-22 |
University Of Florida Research Foundation, Inc. |
Chimeric vectors
|
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
|
HUE030719T2
(en)
|
2007-04-09 |
2017-05-29 |
Univ Florida |
Raav vector compositions having tyrosine-modified capsid proteins and methods for use
|
|
WO2009137006A2
(en)
|
2008-04-30 |
2009-11-12 |
The University Of North Carolina At Chapel Hill |
Directed evolution and in vivo panning of virus vectors
|
|
US8889641B2
(en)
|
2009-02-11 |
2014-11-18 |
The University Of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
US9353164B2
(en)
|
2009-10-29 |
2016-05-31 |
Vib Vzw |
Cardiac-specific nucleic acid regulatory elements and methods and use thereof
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
CN107012171B
(zh)
|
2011-04-22 |
2021-07-13 |
加利福尼亚大学董事会 |
具有变异衣壳的腺相关病毒病毒体及其使用方法
|
|
WO2013078316A1
(en)
|
2011-11-23 |
2013-05-30 |
Nationwide Children's Hospital, Inc. |
Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
|
|
JP6809789B2
(ja)
*
|
2013-01-17 |
2021-01-06 |
メディツィーニシェ・ホーホシューレ・ハノーファーＭｅｄｉｚｉｎｉｓｃｈｅ Ｈｏｃｈｓｃｈｕｌｅ Ｈａｎｎｏｖｅｒ |
疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤
|
|
CN105848720A
(zh)
|
2013-09-12 |
2016-08-10 |
哈佛理事会 |
用于诱导葡萄糖摄取的方法
|
|
US10072251B2
(en)
|
2014-02-19 |
2018-09-11 |
University Of Massachusetts |
Recombinant AAVS having useful transcytosis properties
|
|
ES2768763T3
(es)
|
2014-03-04 |
2020-06-23 |
Univ Florida |
Vectores rAAV mejorados y métodos para la transducción de fotorreceptores y células EPR
|
|
US10370432B2
(en)
|
2014-10-03 |
2019-08-06 |
University Of Massachusetts |
Heterologous targeting peptide grafted AAVS
|
|
RU2020140209A
(ru)
|
2014-10-21 |
2021-01-25 |
Юниверсити Оф Массачусетс |
Варианты рекомбинантных aav и их применения
|
|
EP3875593A1
(en)
|
2015-12-11 |
2021-09-08 |
California Institute of Technology |
Targeting peptides for directing adeno-associated viruses (aavs)
|
|
BR112018011881A2
(pt)
|
2015-12-14 |
2018-12-04 |
The University Of North Carolina At Chapel Hill |
proteínas capsidiais modificadas para liberação aumentada de vetores de parvovírus
|
|
US10570183B2
(en)
|
2016-04-19 |
2020-02-25 |
The Board Of Regents Of The University Of Texas System |
Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload
|
|
WO2017192750A1
(en)
|
2016-05-04 |
2017-11-09 |
Oregon Health & Science University |
Recombinant adeno-associated viral vectors
|
|
EP3469073B1
(en)
|
2016-06-09 |
2024-01-10 |
Centre National de la Recherche Scientifique (CNRS) |
Raav with chemically modified capsid
|
|
WO2018026766A1
(en)
|
2016-08-01 |
2018-02-08 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Compositions and methods for treating cardiac injury
|
|
CA3052829A1
(en)
|
2017-02-15 |
2018-08-23 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for gene transfer across the vasculature
|
|
AU2018225436B2
(en)
|
2017-02-24 |
2023-07-13 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods relating to myomixer-promoted muscle cell fusion
|
|
EP4653536A3
(en)
*
|
2017-03-17 |
2026-02-25 |
Adverum Biotechnologies, Inc. |
Compositions and methods for enhanced gene expression
|
|
WO2018222503A1
(en)
|
2017-05-31 |
2018-12-06 |
The Regents Of The University Of California |
Adeno-associated virus with variant capsid and methods of use thereof
|
|
TWI832036B
(zh)
|
2017-08-03 |
2024-02-11 |
美商航海家醫療公司 |
用於aav之遞送之組合物及方法
|
|
GB2571704A
(en)
*
|
2018-02-22 |
2019-09-11 |
Georg August Univ Gottingen Stiftung Offentlichen Rechts Univer Sitatsmedzin Goettingen |
Prevention or treatment of cardiac arrhytmia and sudden cardiac death
|
|
WO2020014523A1
(en)
*
|
2018-07-12 |
2020-01-16 |
Rocket Pharmaceuticals, Ltd. |
Gene therapy vectors for treatment of danon disease
|
|
WO2020047467A2
(en)
*
|
2018-08-30 |
2020-03-05 |
Tenaya Therapeutics, Inc. |
Cardiac cell reprogramming with myocardin and ascl1
|
|
JP7590968B2
(ja)
|
2018-12-05 |
2024-11-27 |
アビオナ・セラピュ―ティクス・インコーポレイテッド |
遺伝子送達のための組み換えアデノ随伴ウイルスベクター
|
|
AU2019419494B2
(en)
*
|
2018-12-31 |
2026-03-26 |
Research Institute At Nationwide Children's Hospital |
DUX4 RNA silencing using RNA targeting CRISPR-Cas13b
|
|
AR118465A1
(es)
|
2019-03-21 |
2021-10-06 |
Stridebio Inc |
Vectores de virus adenoasociados recombinantes
|
|
AU2020248116B2
(en)
|
2019-03-28 |
2025-12-04 |
President And Fellows Of Harvard College |
Engineered adeno-associated (AAV) vectors for transgene expression
|
|
EP4087489B1
(en)
|
2020-01-08 |
2025-05-14 |
Vitruvia Holdings Inc. |
Methods and computing system for processing ultrasound image to determine health of subdermal tissue
|
|
WO2021163357A2
(en)
*
|
2020-02-13 |
2021-08-19 |
Tenaya Therapeutics, Inc. |
Gene therapy vectors for treating heart disease
|
|
AU2021306697A1
(en)
|
2020-07-07 |
2023-02-09 |
The Board Of Regents Of The University Of Texas System |
Adeno-associated virus vector for dwarf open reading frame
|
|
IL300263A
(en)
*
|
2020-08-07 |
2023-03-01 |
Spacecraft Seven Llc |
Plakophilin-2 (PKP2) gene therapy using an AAV vector
|
|
MX2024000175A
(es)
|
2021-07-08 |
2024-03-05 |
Tenaya Therapeutics Inc |
Casetes de expresión optimizada para genoterapia.
|